Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice

被引:49
作者
Ansaria, Mohammed Javeed I. [1 ,2 ]
Fiorina, Paolo [1 ,2 ,3 ]
Dada, Shirine [1 ,2 ]
Guleria, Indira [1 ,2 ]
Ueno, Takuya [1 ,2 ,4 ]
Yuan, Xueli [1 ,2 ]
Trikudanathan, Subbulaxmi [1 ,2 ]
Smith, R. Neal
Freeman, Gordon [5 ]
Sayegh, Mohamed H. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA
[3] Ist Sci San Raffaele, I-20132 Milan, Italy
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
ICOS; costimulation; sirolimus; autoimmune diabetes; NOD mice; islet transplantation;
D O I
10.1016/j.clim.2007.07.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Islet allografts are subject to alloimmune and autoimmune destruction when transplanted into autoimmune prone animals or humans. The ICOS-B7h pathway plays a role in alloimmune responses, but its function in autoimmunity against islet cells is controversial. We investigated the role of ICOS signaling in autoimmune and alloimmune responses in NOD mice. ICOS blockade prevents development of spontaneous disease in pre-diabetic NOD mice. Furthermore, while ICOS blockade prolongs graft survival in a fully mismatched non-autoimmune islet allograft model in C57BL/6 recipients, it has no beneficial effect in reversing diabetes in models of islet transplantation in NOD mice involving autoimmunity alone or both allo- and autoimmunity. Interestingly, ICOS blockade is effective in prolonging heart allograft (not subject to tissue-specific autoimmunity) survival in NOD mice. We conclude that in islet transplantation and autoimmune diabetes, ICOS blockade can be effective in inhibiting alloimmunity and preventing autoimmunity but is ineffective in inhibiting recurrence of autoimmunity. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 33 条
  • [1] The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
    Ansari, MJI
    Salama, AD
    Chitnis, T
    Smith, RN
    Yagita, H
    Akiba, H
    Yamazaki, T
    Azuma, M
    Iwai, H
    Khoury, SJ
    Auchincloss, H
    Sayegh, MH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) : 63 - 69
  • [2] The NOD mouse model of type 1 diabetes: As good as it gets?
    Atkinson, MA
    Leiter, EH
    [J]. NATURE MEDICINE, 1999, 5 (06) : 601 - 604
  • [3] BAEDER WL, 1992, CLIN EXP IMMUNOL, V89, P174
  • [4] EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
  • [5] Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation
    Guo, L
    Fujino, M
    Kimura, H
    Funeshima, N
    Kitazawa, Y
    Harihara, Y
    Tezuka, K
    Makuuchi, M
    Suzuki, S
    Li, XK
    [J]. TRANSPLANT IMMUNOLOGY, 2003, 12 (01) : 41 - 48
  • [6] Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS)
    Guo, L
    Li, XK
    Funeshima, N
    Fujino, M
    Nagata, Y
    Kimura, H
    Amemiya, H
    Enosawa, S
    Tsuji, T
    Harihara, Y
    Makuuchi, M
    Suzuki, S
    [J]. TRANSPLANTATION, 2002, 73 (07) : 1027 - 1032
  • [7] The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity
    Harada, H
    Salama, AD
    Sho, M
    Izawa, A
    Sandner, SE
    Ito, T
    Akiba, H
    Yagita, H
    Sharpe, AH
    Freeman, GJ
    Sayegh, MH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (02) : 234 - 243
  • [8] CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion
    Herman, AE
    Freeman, GJ
    Mathis, D
    Benoist, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) : 1479 - 1489
  • [9] Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    Herold, KC
    Hagopian, W
    Auger, JA
    Poumian-Ruiz, E
    Taylor, L
    Donaldson, D
    Gitelman, SE
    Harlan, DM
    Xu, DL
    Zivin, RA
    Bluestone, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) : 1692 - 1698
  • [10] ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
    Hutloff, A
    Dittrich, AM
    Beier, KC
    Eljaschewitsch, B
    Kraft, R
    Anagnostopoulos, I
    Kroczek, RA
    [J]. NATURE, 1999, 397 (6716) : 263 - 266